ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

Senate Bill Includes $10 Billion for NIH

February 6, 2009

Cancer Informatics: NCI Calls On Users To Help Redesign Physician’s Data Query

February 13, 1998

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991